Skip to content
OpenCapital
Get started

Aurinia Pharmaceuticals AUPH Enterprise value

Enterprise value at other companies

Rogers Corporation logo
Rogers CorporationROG
$1.75B+57.7%
Vera Therapeutics logo
Vera TherapeuticsVERA
$2.83B+85.0%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$1.83B-51.1%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$1.9B+15.2%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$16.77B+178%
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
$3.5B+139%

Other financials

Income statement

See full
Revenue$77.7M+24.4%
Gross profit$71.2M+32.1%
Operating income$41.4M+89.6%
Net income$34.4M+47.2%
EPS (diluted)$0.25+56.3%

Balance sheet

See full
Cash & equivalents$41.0M-38.3%
Total debt$85.2M-7.9%
Total equity$567.6M+62.1%
Total assets$724.0M+43.4%

Cash flow

See full
Operating cash flow$32.6M+2,405%

Valuation

See full
Market cap$2.3B+78.5%
P/E7.7×-24.6×
P/S7.7×+2.5×

Profitability

See full
Gross margin89.7%+1.5pp
Operating margin41.7%+29.4pp
Net margin100%+83.9pp

Returns & leverage

See full
Return on equity65%+53.8pp
Debt / equity0.2×-0.1×
Current ratio5.5×-0.4×

Where this comes from

Calculated from Aurinia Pharmaceuticals’s reported figures.

$2.0Bmarket cap+$85.2Mtotal debt−$41.0Mcash and equivalents=$2.01B

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aurinia Pharmaceuticals's enterprise value?
Aurinia Pharmaceuticals (AUPH) reported enterprise value of $2.01B in Q1 2026.
How has Aurinia Pharmaceuticals's enterprise value changed year-over-year?
Aurinia Pharmaceuticals's enterprise value increased by 78.3% year-over-year, from $1.13B to $2.01B.
What is the long-term trend for Aurinia Pharmaceuticals's enterprise value?
Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's enterprise value has grown at a 4.3% compound annual growth rate (CAGR), from $1.71B to $2.11B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.